Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Wood

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Pharmacology|August 13, 1982
Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitorsP L Wood
Current Opinion in Drug Discovery & Development|August 4, 2009
Peptoid drug discovery: the choice of scaffolds for combinatorial chemistry/HTS and subsequent substitutions for parallel synthesis/lead optimizationP L Wood
Life Sciences|January 1, 1994
Differential regulation of IL-1 alpha and TNF alpha release from immortalized murine microglia (BV-2)P L Wood
Neurological Research|August 1, 1995
Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microgliaP L Wood
Biomedical Mass Spectrometry|July 1, 1982
A selected ion monitoring assay for dopamine and its metabolites using negative chemical ionizationP L Wood
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the ratP L Wood
Neuropharmacology|June 1, 1982
Multiple opiate receptors: support for unique mu, delta and kappa sitesP L Wood
Idrugs : the Investigational Drugs Journal|May 10, 2008
Inhibitors of apoptosis, APP processing and prostaglandin formation: disease modifying drugs for Alzheimer's disease?P L Wood
Pharmacological Reviews|March 1, 1991
Pharmacology of the second messenger, cyclic guanosine 3',5'-monophosphate, in the cerebellumP L Wood
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
CCK modulation of cerebellar afferents: dopaminergic involvementP L Wood
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Pharmacology|August 13, 1982
Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitorsP L Wood
Current Opinion in Drug Discovery & Development|August 4, 2009
Peptoid drug discovery: the choice of scaffolds for combinatorial chemistry/HTS and subsequent substitutions for parallel synthesis/lead optimizationP L Wood
Life Sciences|January 1, 1994
Differential regulation of IL-1 alpha and TNF alpha release from immortalized murine microglia (BV-2)P L Wood
Neurological Research|August 1, 1995
Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microgliaP L Wood
Biomedical Mass Spectrometry|July 1, 1982
A selected ion monitoring assay for dopamine and its metabolites using negative chemical ionizationP L Wood
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1982
Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the ratP L Wood
Neuropharmacology|June 1, 1982
Multiple opiate receptors: support for unique mu, delta and kappa sitesP L Wood
Idrugs : the Investigational Drugs Journal|May 10, 2008
Inhibitors of apoptosis, APP processing and prostaglandin formation: disease modifying drugs for Alzheimer's disease?P L Wood
Pharmacological Reviews|March 1, 1991
Pharmacology of the second messenger, cyclic guanosine 3',5'-monophosphate, in the cerebellumP L Wood
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
CCK modulation of cerebellar afferents: dopaminergic involvementP L Wood
Pageof 22